AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to ...

A selective protein degradation system known as Golgi membrane-associated degradation (GOMED), which identifies and removes ...

A selective protein degradation system known as Golgi membrane-associated degradation (GOMED), which identifies and removes ...

Background Up to half of patients with infective endocarditis (IE) require cardiac surgery. Although anaemia is common, its ...

In the world of biomechanics and medicine, there are challenges in the designing microrobots that are effective in drug administration. Properly managing factors such as biocompatibility, size, ...

Yasmin Mowat recieves funding from a National Health and Medical Research Council (NHMRC) Partnership Grant, implemented with Lifeblood. David Irving works for Australian Red Cross Lifeblood and is ...

OpenAI CEO Sam Altman has declared “code red” at the company, refocusing all resources into improving the quality of its flagship product ChatGPT and delaying other initiatives, some of which are yet ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is led by former ...

Dear Dr. Roach: I had an eye issue last year that led to blood tests resulting in an elevated A1C. I said that it wasn't my blood; I am plant-based, exercise regularly, and don't drink sodas or ...

Gene variants in red blood cell function may have doomed the hybrid babies of Neanderthals and modern humans. When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

University of Cambridge scientists have used human stem cells to create three-dimensional embryo-like structures that replicate certain aspects of very early human development - including the ...